Navigation Links
Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
Date:6/11/2009

nd remained the same or decreased over four years of continuous treatment.

To view the EULAR poster presentation reporting results of the Phase 2 long-term continuation study of BENLYSTA through four years, click here.

About the Phase 2 Study of BENLYSTA in SLE

The primary objectives of the Phase 2 study were to evaluate the efficacy and safety of belimumab (BENLYSTA) plus standard of care, versus placebo plus standard of care. A total of 449 patients with active SLE were randomized to receive one of three different doses of belimumab (1, 4 or 10 mg/kg) or placebo administered intravenously over a 52-week treatment period, in addition to standard-of-care therapy. At the end of 52 weeks, 345 patients chose to participate in an optional 24-week extension phase of the study, during which all patients received belimumab. At Week 76, 296 patients chose to remain on belimumab treatment in an open-label long-term continuation phase of the Phase 2 trial, in which all patients are receiving 10 mg/kg belimumab. As of June 1, 2009, 213 patients remained on belimumab treatment in the continuation study.

In June 2006, HGS reported the 52-week results of the Phase 2 trial, which demonstrated that belimumab significantly reduced disease activity versus placebo in patients with serologically active SLE across multiple clinical measures, exhibited clinically relevant biological activity, and appeared generally safe and well tolerated. Frequency and severity of adverse events were similar to placebo. Among the findings at Week 52 was a significantly improved response rate among serologically active patients, as defined by an improvement in SELENA SLEDAI score of 4 points or greater, no new BILAG A flare and no more than one new BILAG B flare, and n
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
2. New MIT radio chip mimics human ear
3. deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease
4. Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement
5. Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments
6. FDA has Granted HUD (Humanitarian Use Device) Designation to ITGIs Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Grafts
7. STEMCELL Technologies Introduces a New Animal Component-Free, Serum-Free Medium for Culturing Human Mesenchymal Stem Cells
8. CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
9. Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2009 Financial Results
10. The Journal of Cardiac Failure Publishes Results From Celladon Corporations First-in-Human Phase 1/2 Clinical Trial in Advanced Heart Failure
11. ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... With the ability to record continuously at ... than 15 minutes, Fastec Imaging has brought the same ease-of-use ... imaging. “Finally, a high speed camera that can be used ... everyday lives.” proclaims Matt Kearney, VP of Sales for Fastec ... demystify and simplify the traditionally complicated workflow of a high ...
(Date:7/23/2014)... 2014 a2z Inc. announces that AACC ... AACC Pathfinder, in its 2014 Annual Meeting & ... is planned for July 29-31, 2014 in Chicago, IL ... to connect with global leaders in clinical chemistry, molecular ... areas of breaking science in laboratory medicine. , ChirpE ...
(Date:7/23/2014)... July 23, 2014 Astra ... and comprehensive consultancy and pharma training services, and ... Safety (ACRES) , a non-profit integrating the expertise ... and maintain a global system for clinical trials, ... to improve the expertise of industry professionals through ...
(Date:7/22/2014)... LAKES, N.J. , July 22, 2014 The ... BDX ) has declared a quarterly dividend of ... to holders of record on September 9, 2014. The indicated ... About BD BD is a leading medical technology ... of the world,s most pressing and evolving health needs. Our ...
Breaking Biology Technology:Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3
... $68.6 Million, Increase of 32% Over Second Quarter 2007, - EPS of ... - Earnings Before Non-Cash Charges of $1.36 per Basic Share, Increase of ... 56% Over Second ... UTHR ) today announced its results of,operations for the quarter ended ...
... California, Berkeley, have devised a way to squeeze light ... doors to new technology in the fields of optical ... succeeded previously in passing light through gaps 200 nanometers ... a human hair. A group of UC Berkeley researchers ...
... Inc.,(Nasdaq: ITMN ) today announced that Daniel G. ... the BMO Capital Markets 2008 Focus,on Healthcare Conference in ... EDT., To access a live audio webcast of ... to the investor relations page of InterMune,s,corporate website at ...
Cached Biology Technology:United Therapeutics Reports Second Quarter 2008 Financial Results 2United Therapeutics Reports Second Quarter 2008 Financial Results 3United Therapeutics Reports Second Quarter 2008 Financial Results 4United Therapeutics Reports Second Quarter 2008 Financial Results 5United Therapeutics Reports Second Quarter 2008 Financial Results 6New technique to compress light could open doors for optical communications 2New technique to compress light could open doors for optical communications 3
(Date:7/23/2014)... In Aesop,s fable about the crow and the pitcher, a ... he tries to drink from it, he finds the water ... over the pitcher, the bird drops pebbles into it ... enough for him to drink his fill. , Highlighting the ... often be more effective than brute force. It also characterizes ...
(Date:7/23/2014)... satellite over a 15-year period off the U.S. West ... in specific locations each year, according to a study ... PLOS ONE by Ladd Irvine from Oregon State ... mitigate human threats to the whale population. , The ... since the establishment of protections in the mid-1960s. Scientists ...
(Date:7/23/2014)... Spinach gave Popeye super strength, but it also ... group of scientists: the ability to convert sunlight into ... are part of an international group using spinach to ... which plants convert the sun,s energy into carbohydrates used ... are part of the most efficient system ever built, ...
Breaking Biology News(10 mins):Smarter than a first-grader? 2Smarter than a first-grader? 3Smarter than a first-grader? 4Blue whales' dangerous feeding grounds 2Spinach could lead to alternative energy more powerful than Popeye 2
... study of men and post-menopausal women primarily over 60 ... with greater bone mineral density (BMD). Researchers at the ... (USDA HNRCA) at Tufts University found associations were strongest ... lower in men drinking more than two servings of ...
... -- Ben-Gurion University of the Negev (BGU) researchers have ... reversible panes that will save energy all year round ... Window, features the only glazing system that permits effective ... temperature near a window and reduces unwanted solar gains ...
... of the American Dietetic Association features research studies ... of the life cycle, from children and adolescents to ... Consumption among U.S. Children , Children and adolescents ... to researchers at Ohio State University. The researchers ...
Cached Biology News:Moderate alcohol intake associated with bone protection 2Moderate alcohol intake associated with bone protection 3Ben-Gurion University of the Negev researchers develop new reversible, green window technology 2News from the March 2009 Journal of the American Dietetic Association 2
Lentigen's manufacturing platform is sufficiently versatile for use in the manufacture of any HIV-based Lentiviral vector. Lentigen will manufacture your LV of choice to the highest possible titer a...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: